ValerieReneeSuskiDO

Clinical Trials

• A Study of the Novel Drug Dimebon in Patients With Huntington's Disease Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01

  Terminated

  Phase 3

• Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease Start of enrollment: 2011 Mar 24

  Completed

  Phase 2

• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01

  Recruiting

• A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease Start of enrollment: 2014 Feb 28

  Completed

  Phase 2

• Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease Start of enrollment: 2016 May 10

  Completed

  Phase 2

• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Start of enrollment: 2016 Feb 11

  Completed

  Phase 4

• Development of the Virtual Unified Huntington's Disease Rating Scale Start of enrollment: 2022 Sep 22

  Completed

  Roles: Contact

• Join now to see all